Petru Bucur
Overview
Explore the profile of Petru Bucur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adam R, Piedvache C, Chiche L, Adam J, Salame E, Bucur P, et al.
Lancet
. 2024 Sep;
404(10458):1107-1118.
PMID: 39306468
Background: Despite the increasing efficacy of chemotherapy, permanently unresectable colorectal liver metastases are associated with poor long-term survival. We aimed to assess whether liver transplantation plus chemotherapy could improve overall...
2.
Kockelmann F, Giger-Pabst U, Ouaissi M, Bucur P, Barbey S, VON Ardenne A, et al.
Anticancer Res
. 2024 Jun;
44(7):3043-3050.
PMID: 38925817
Background/aim: This study evaluated the feasibility and safety of whole-body hyperthermia pressurized intraperitoneal aerosol chemotherapy (WBH-PIPAC) in patients with peritoneal surface malignancies. Patients And Methods: This study retrospectively analyzed a...
3.
Rogier-Mouzelas F, Piquard A, Karam E, Dussart D, Michot N, Saint-Marc O, et al.
Surg Endosc
. 2024 May;
38(7):3738-3757.
PMID: 38789622
Background: It is assumed that robotic-assisted surgery (RAS) may facilitate complex pelvic dissection for rectal cancer compared to the laparoscopic-assisted resection (LAR). The aim of this study was to compare...
4.
Adam R, Badrudin D, Chiche L, Bucur P, Scatton O, Granger V, et al.
EClinicalMedicine
. 2024 May;
72:102608.
PMID: 38721015
Background: Despite the increasing efficacy of chemotherapy (C), the 5-year survival rate for patients with unresectable colorectal liver metastases (CLM) remains around 10%. Liver transplantation (LT) might offer a curative...
5.
Bekheit M, Grundy L, Salih A, Bucur P, Vibert E, Ghazanfar M
Hepatobiliary Pancreat Dis Int
. 2023 Mar;
22(6):554-569.
PMID: 36973111
Background: Post-hepatectomy liver failure (PHLF) is a leading cause of postoperative mortality after liver surgery. Due to its significant impact, it is imperative to understand the risk stratification and preventative...
6.
Hoehme S, Hammad S, Boettger J, Begher-Tibbe B, Bucur P, Vibert E, et al.
iScience
. 2023 Jan;
26(1):105714.
PMID: 36691615
Partial liver removal is an important therapy option for liver cancer. In most patients within a few weeks, the liver is able to fully regenerate. In some patients, however, regeneration...
7.
Seckler F, Turco C, Mohkam K, Addeo P, Robin F, Cauchy F, et al.
Transplantation
. 2022 Dec;
107(3):664-669.
PMID: 36477606
Background: In the current setting of organ shortage, brain-dead liver donors with recent liver trauma (RLT) represent a potential pool of donors. Yet, data on feasibility and safety of liver...
8.
Mohkam K, Nasralla D, Mergental H, Muller X, Butler A, Jassem W, et al.
Liver Transpl
. 2022 Jun;
28(11):1716-1725.
PMID: 35662403
In situ normothermic regional perfusion (NRP) and ex situ normothermic machine perfusion (NMP) aim to improve the outcomes of liver transplantation (LT) using controlled donation after circulatory death (cDCD). NRP...
9.
Lepoittevin M, Giraud S, Kerforne T, Barrou B, Badet L, Bucur P, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563381
Organ transplantation remains the treatment of last resort in case of failure of a vital organ (lung, liver, heart, intestine) or non-vital organ (essentially the kidney and pancreas) for which...
10.
Karam E, Bucur P, Gil C, Sindayigaya R, Tabchouri N, Barbier L, et al.
BMC Gastroenterol
. 2022 Apr;
22(1):201.
PMID: 35448953
Background: Colorectal cancer is the third most common cancer in France and by the time of the diagnosis, 15-25% of patients will suffer from synchronous liver metastases. Surgery associated to...